Taurchini Marco, Cuttitta Antonello
Unit of Thoracic Surgery, Casa Sollievo della Sofferenza Hospital, IRCCS, San Giovanni Rotondo, Italy.
J Vis Surg. 2017 Sep 14;3:125. doi: 10.21037/jovs.2017.08.23. eCollection 2017.
Esophageal cancer is the eight most common cancer in the world and surgical resection remains the gold standard not only in providing the optimal chance for cure but also the best palliation for dysphagia. Esophagectomy is a complex operation and is associated with significant morbidity and mortality that are reported as 23-50% and 2-8% in western country. At the moment no gold standard techniques exist for esophagectomy. The choice of the technique depends on several factors; location of tumor and surgeon's experience are probably the most relevant. Minimally invasive esophagectomy (MIE), performed in high volume centers, has shown to reduce the rate of complications with the same oncological outcome as open esophagectomy. The addition of robotic technique to MIE is relatively new and is gaining widespread acceptance. Robotic assisted minimally invasive esophagectomy (RAMIE) is safe and feasible, and its short-term results are comparable to conventional MIE. Randomized studies are needed to assess if there is any real benefit associated to the use of the robotic approach.
食管癌是全球第八大常见癌症,手术切除不仅是实现治愈最佳机会的金标准,也是缓解吞咽困难的最佳方法。食管切除术是一项复杂的手术,其并发症发生率和死亡率都很高,在西方国家分别为23%-50%和2%-8%。目前,食管切除术尚无金标准技术。技术的选择取决于几个因素;肿瘤位置和外科医生的经验可能是最相关的因素。在大型中心进行的微创食管切除术(MIE)已显示可降低并发症发生率,且肿瘤学结局与开放食管切除术相同。将机器人技术应用于MIE相对较新,且正在得到广泛认可。机器人辅助微创食管切除术(RAMIE)安全可行,其短期效果与传统MIE相当。需要进行随机研究来评估使用机器人手术方法是否真的有任何益处。